Last week, our Chief Scientific Officer, Matthew Stanton, discussed the key hurdles for non-viral DNA delivery and innate immune stimulation, as well as strategies to address these challenges in an online webinar with the Oligonucleotide Therapeutics Society. Check it out here to learn more: https://bit.ly/45yQjxs
Excellent presentation!
Preclinical and Translational Development | In Vivo Pharmacology
10moawesome presentation! Thank you